Cardiotoxicity of checkpoint inhibitors: focus on immune side effects
Objective: The use of checkpoint inhibitors in cancer will continue to expand in the coming years, which is a promising area for future clinical research. However, diagnosis of immune-related side effects is challenging due to its heterogeneous clinical manifestations, which range from subclinical t...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Center for Scientific Research and Development of Education.
2024-04-01
|
| Serija: | Heart Vessels and Transplantation |
| Teme: | |
| Online dostop: | https://hvt-journal.com/articles/art480 |
| Oznake: |
Brez oznak, prvi označite!
|